Deal Tracker · Countries
UAE pharma deals
61 pharma deals involving UAE — companies based there or deals covering the market — tracked by EPT: distribution, partnerships & licensing. Most active: ADCAN Pharma, Mubadala Bio, Arcera Life Sciences & Department of Health – Abu Dhabi. Latest: Innogen Pharmaceuticals → Arcera Life Sciences (Licensing, 19 Nov 2026).
- EPT has tracked 61 UAE pharma deals (2020–2026), 53 of them announced in 2026.
- The most common structures are distribution (28%), partnerships (21%) & licensing (20%).
- Values were disclosed for 5 of 61 deals, totalling $1.4bn; the largest is AriBio → Arcera Life Sciences ($600m, 10 Jun 2025).
- The most active companies: ADCAN Pharma (13), Mubadala Bio (8), Arcera Life Sciences (6) & Department of Health – Abu Dhabi (4).
- Innogen Pharmaceuticals → Arcera Life SciencesLicensing · Global (LMICs) · Undisclosed · 19 Nov 2026
- Emmaus Life Sciences → Al Wataniya AldawliyaDistribution · MENA · Undisclosed · 12 Nov 2026
- Emirates Drug Establishment → ViatrisPartnership / Collaboration · GCC · Undisclosed · 11 Nov 2026
- Viatris → ADCAN PharmaTechnology transfer / Localization · GCC · Undisclosed · 11 Nov 2026
- Hikma Ventures → Rem3dy HealthEquity / Investment · MENA · Undisclosed · 11 Nov 2026
- M42 → ADCAN PharmaPartnership / Collaboration · GCC · Undisclosed · 9 Nov 2026
- Korea Pharmbio → Ashro Drug StoreDistribution · GCC · Undisclosed · 3 Nov 2026
- Geropharm → Al Quds Medical ProductsTechnology transfer / Localization · MENA · Undisclosed · 3 Nov 2026
- Roche Pharmaceuticals UAE → Department of Health – Abu DhabiPartnership / Collaboration · GCC · Undisclosed · 2 Nov 2026
- Galenicum → Al Ittihad Drug StoreDistribution · GCC · Undisclosed · 31 Oct 2026
- Rem3dy Health → Hikma PharmaceuticalsDistribution · GCC · Undisclosed · 29 Oct 2026
- Novartis → Department of Health – Abu DhabiPartnership / Collaboration · GCC · Undisclosed · 28 Oct 2026
- Pinnacology Research & Development → Prognica LabsPartnership / Collaboration · GCC · Undisclosed · 25 Oct 2026
- Mubadala Bio → Arabian EthicalsDistribution · GCC · 22 Oct 2026
- Miltenyi Biomedicine → Abu Dhabi Stem Cells CenterPartnership / Collaboration · GCC · 22 Oct 2026
- Abbott → Mubadala BioTechnology transfer / Localization · GCC · 22 Oct 2026
- Department of Health – Abu Dhabi / Cleveland Clinic Abu Dhabi → AstraZenecaGCC · See terms · 21 Oct 2026
- Department of Health – Abu Dhabi → WHOOPGCC · 21 Oct 2026
- Department of Health – Abu Dhabi → Isomorphic LabsGCC · 21 Oct 2026
- Mubadala Bio → Modern PharmaceuticalDistribution · GCC · 21 Oct 2026
- Mubadala Bio → Jamjoom PharmaDistribution · GCC · 21 Oct 2026
- Marcyrl Pharmaceutical Industries → Mubadala BioTechnology transfer / Localization · GCC · 21 Oct 2026
- MS Pharma → ADCAN PharmaTechnology transfer / Localization · GCC · 20 Oct 2026
- Sanofi → Mubadala BioDistribution · GCC · 20 Oct 2026
- Eli Lilly → Mubadala BioSupply / Manufacturing · GCC · Undisclosed · 20 Oct 2026
- DKSH → NewBridge PharmaceuticalsM&A / Acquisition · MENA · $390m · 19 Oct 2026
- Macleods Pharmaceuticals → New Country HealthcareDistribution · GCC · 17 Oct 2026
- ADCAN Pharma → Zulekha Medical StoreDistribution · GCC · Undisclosed · 15 Oct 2026
- Inventia Healthcare → ADCAN PharmaLicensing · GCC · 14 Oct 2026
- Lotus Pharmaceutical → ADCAN PharmaLicensing · MENA · 9 Oct 2026
- Genepharm → ADCAN PharmaLicensing · GCC · 9 Oct 2026
- Alvion Pharmaceuticals → ADCAN PharmaLicensing · GCC · 8 Oct 2026
- Elpen → ADCAN PharmaLicensing · GCC · 8 Oct 2026
- ADCAN Pharma → Pharma ResourcesPartnership / Collaboration · GCC · 8 Oct 2026
- Elpen → ADCAN PharmaLicensing · GCC · 7 Oct 2026
- Dar Al Dawa → MicroSynergy PharmaSupply / Manufacturing · GCC · Undisclosed · 30 Sept 2026
- Cordex Biologics → Farma MondoDistribution · GCC · 25 Sept 2026
- Global Pharma → PrinceFarmaDistribution · Africa · Undisclosed · 17 Sept 2026
- Pinnacle Life Science → ADCAN PharmaLicensing · GCC · Undisclosed · 2 Sept 2026
- Alfasigma → Nordic PharmaM&A / Acquisition · Global ex-US · See terms · 9 Aug 2026
- SPIMACO → Cigalah Drug StoreDistribution · GCC · Undisclosed · 30 Jul 2026
- JCR Pharmaceuticals → Taiba HealthcareDistribution · MENA · Undisclosed · 21 Jul 2026
- Bausch Health → AUG PharmaM&A / Acquisition · GCC · Undisclosed · 12 Jul 2026
- Daewoong Pharmaceutical → Arcera Life SciencesLicensing · MENA · $94m · 29 Jun 2026
- Biosidus → Mubadala BioLicensing · GCC · Undisclosed · 24 Jun 2026
- Menarini → ADCAN PharmaTechnology transfer / Localization · GCC · Undisclosed · 12 Jun 2026
- Novo Nordisk → Emirates Drug EstablishmentPartnership / Collaboration · GCC · Undisclosed · 8 Jun 2026
- M42 → Arcera Life SciencesPartnership / Collaboration · GCC · Undisclosed · 3 Jun 2026
- Emirates Drug Establishment → Arcera Life SciencesPartnership / Collaboration · GCC · Undisclosed · 5 May 2026
- LifePharma → BurjeelJoint venture · GCC · $27.2m · 3 May 2026
- Fosun Pharma → Arcera Life SciencesPartnership / Collaboration · GCC · Undisclosed · 28 Apr 2026
- Misk Pharmaceutical Industries → UNIMED LaboratoriesDistribution · GCC · Undisclosed · 12 Feb 2026
- Chemo & Olpha → CCL PharmaceuticalsSupply / Manufacturing · GCC · Undisclosed · 28 Jan 2026
- Accord Healthcare → Dar Al Dawaa Al ArabiyaDistribution · GCC · Undisclosed · 3 Dec 2025
- Faes Farma → SIFIM&A / Acquisition · Global (LMICs) · $310m · 2 Sept 2025
- AriBio → Arcera Life SciencesLicensing · Global (LMICs) · $600m · 10 Jun 2025
- EQL Pharma → PharmalinkDistribution · GCC · See terms · 11 Mar 2025
- Kelix Bio → Khalifa University of Science & Technology + Mubadala InvestmentPartnership / Collaboration · GCC · Undisclosed · 30 Apr 2024
- Sunshine Lake Pharma → JulpharLicensing · MENA · Undisclosed · 18 May 2023
- Huadong Medicine → JulpharPartnership / Collaboration · MENA · Undisclosed · 25 Jun 2022
- Sinopharm → G42Joint venture · MENA · 1 Jul 2020
Most active companies
ADCAN Pharma (13) · Mubadala Bio (8) · Arcera Life Sciences (6) · Department of Health – Abu Dhabi (4) · Emirates Drug Establishment (3) · Elpen (2)
Largest disclosed deals
- AriBio → Arcera Life Sciences · $600m · Licensing · 10 Jun 2025
- DKSH → NewBridge Pharmaceuticals · $390m · M&A / Acquisition · 19 Oct 2026
- Faes Farma → SIFI · $310m · M&A / Acquisition · 2 Sept 2025
Questions
- How many UAE pharma deals has EPT tracked?
- 61 as of 19 Nov 2026, covering 2020–2026; 53 were announced in 2026. The most recent is Innogen Pharmaceuticals → Arcera Life Sciences (Licensing, 19 Nov 2026).
- What types of UAE pharma deals are most common?
- Distribution: 17 (28%); Partnership / Collaboration: 13 (21%); Licensing: 12 (20%); Technology transfer / Localization: 6 (10%).
- Which companies are most active in UAE pharma deals?
- ADCAN Pharma (13 deals), Mubadala Bio (8 deals), Arcera Life Sciences (6 deals), Department of Health – Abu Dhabi (4 deals), Emirates Drug Establishment (3 deals), Elpen (2 deals).
- What is the largest disclosed UAE pharma deal?
- AriBio → Arcera Life Sciences: $600m (Licensing, 10 Jun 2025); DKSH → NewBridge Pharmaceuticals: $390m (M&A / Acquisition, 19 Oct 2026); Faes Farma → SIFI: $310m (M&A / Acquisition, 2 Sept 2025). Values are as announced by the parties.
Browse deals
By region
GCC (83) · MENA (66) · Africa (17) · Latin America (17) · Southeast Asia (17) · Global (LMICs) (14) · CIS & Central Asia (13) · Türkiye (5) · Global ex-US (1)
By country
Saudi Arabia (69) · China (31) · Egypt (27) · United States (26) · Oman (20) · India (19) · Switzerland (18) · Jordan (14) · South Korea (14) · Kazakhstan (13) · Algeria (12) · Türkiye (12) · United Kingdom (11) · Brazil (10) · Kuwait (10) · Iraq (8) · Morocco (8) · Bahrain (7) · Malaysia (7) · Spain (7) · Argentina (6) · Germany (6) · Indonesia (6) · Philippines (6) · Qatar (6) · Italy (5) · Mexico (5) · Vietnam (5) · France (4) · Taiwan (4) · Tunisia (4) · Canada (3) · Chile (3) · Denmark (3) · Greece (3) · Japan (3) · Lebanon (3) · Nigeria (3) · Pakistan (3) · South Africa (3) · Sweden (3) · Thailand (3) · Azerbaijan (2) · Colombia (2) · Ireland (2) · Kenya (2) · Libya (2) · Netherlands (2) · Singapore (2) · Uruguay (2) · Uzbekistan (2)
By deal type
Licensing (56) · Distribution (41) · Technology transfer / Localization (39) · Partnership / Collaboration (35) · M&A / Acquisition (21) · Equity / Investment (18) · Joint venture (11) · Supply / Manufacturing (10)
Popular searches
MENA pharma licensing deals (25) · Saudi Arabia pharma licensing deals (24) · GCC pharma distribution deals (21) · GCC pharma partnerships (19) · China pharma licensing deals (17) · UAE pharma distribution deals (17) · GCC pharma localization & tech-transfer deals (15) · Saudi Arabia pharma distribution deals (14) · UAE pharma partnerships (13) · UAE pharma licensing deals (12) · Global (LMICs) pharma licensing deals (11) · India pharma licensing deals (11) · GCC pharma licensing deals (10) · MENA pharma partnerships (10) · Saudi Arabia pharma localization & tech-transfer deals (10) · MENA pharma localization & tech-transfer deals (9) · United States pharma licensing deals (9) · Egypt pharma localization & tech-transfer deals (8) · Saudi Arabia pharma partnerships (8) · CIS & Central Asia pharma localization & tech-transfer deals (7) · Kazakhstan pharma localization & tech-transfer deals (7) · MENA pharma distribution deals (7) · MENA pharma M&A deals (7) · United States pharma distribution deals (7)
By company
ADCAN Pharma (13) · Mubadala Bio (8) · Jamjoom Pharma (7) · SPIMACO (7) · Arcera Life Sciences (6) · Hikma Pharmaceuticals (6) · Bio-Thera Solutions (6) · Avalon Pharma (5) · Tabuk Pharmaceuticals (5) · Local Content and Government Procurement Authority (5) · Kazakhstan Ministry of Health (5) · Eva Pharma (4) · Sandoz (4) · Department of Health – Abu Dhabi (4) · Biocon (4) · Groupe Saidal (4) · Gilead Sciences (3) · Dr. Reddy's Laboratories (3) · Emirates Drug Establishment (3) · Novo Nordisk (3) · Khazaen Economic City (3) · Galenicum (3) · Roche (3) · Laprophan (3) · Sanofi (3) · Gen İlaç (3) · Taiba Healthcare (3) · Dar Al Dawa (3) · Lifera (3) · Celltrion (2) · Viatris (2) · Rem3dy Health (2) · AMA Medical Manufacturing (2) · Afreximbank (2) · M42 (2) · Abbott (2) · DKSH (2) · Adalvo (2) · Rameda (2) · Menarini (2) · Korea United Pharm (2) · Samsung Bioepis (2) · AstraZeneca (2) · MS Pharma (2) · LifePharma (2) · Duopharma Biotech (2) · JCR Pharmaceuticals (2) · Philex Pharmaceuticals (2) · Lotus Pharmaceutical (2) · Elpen (2) · Dhofar Pharmaceutical Industries (2) · Accord Healthcare (2) · CCL Pharmaceuticals (2) · Abdi İbrahim (2) · Nordic Pharma (2) · UNIMED Laboratories (2) · Minapharm (2) · SaudiVax (2) · Faes Farma (2) · AJA Pharma (2) · VACSERA (2) · Bayer (2) · Shanghai Henlius Biotech (2) · Julphar (2)
By therapeutic area
Multi-therapy (64) · Oncology (30) · Metabolic / Diabetes (27) · Cardiovascular (17) · Vaccines (15) · Immunology / Inflammation (13) · Rare / Orphan (9) · Infectious Disease (8) · CNS / Neurology (6) · Ophthalmology (6) · Consumer health (5) · Women's Health (4) · Respiratory (2)